KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Quest Diagnostics (DGX) Shares Repurchased: 2009-2024

Historic Shares Repurchased for Quest Diagnostics (DGX) over the last 13 years, with Dec 2024 value amounting to $151.0 million.

  • Quest Diagnostics' Shares Repurchased fell 45.09% to $151.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 billion, marking a year-over-year decrease of 3.74%. This contributed to the annual value of $151.0 million for FY2024, which is 45.09% down from last year.
  • As of Q4 2024, Quest Diagnostics' Shares Repurchased stood at $151.0 million, which was down 45.09% from $275.0 million recorded in Q4 2023.
  • Quest Diagnostics' Shares Repurchased's 5-year high stood at $1.5 billion during Q2 2021, with a 5-year trough of $75.0 million in Q1 2020.
  • Over the past 3 years, Quest Diagnostics' median Shares Repurchased value was $324.0 million (recorded in 2022), while the average stood at $305.7 million.
  • In the last 5 years, Quest Diagnostics' Shares Repurchased spiked by 446.67% in 2021 and then plummeted by 86.67% in 2022.
  • Quest Diagnostics' Shares Repurchased (Quarterly) stood at $250.0 million in 2020, then climbed by 15.60% to $289.0 million in 2021, then skyrocketed by 59.52% to $461.0 million in 2022, then plummeted by 40.35% to $275.0 million in 2023, then tumbled by 45.09% to $151.0 million in 2024.
  • Its last three reported values are $151.0 million in Q4 2024, $275.0 million for Q4 2023, and $461.0 million during Q4 2022.